Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.32 |
| ▸ | PDE7B | Q9NP56 | 2/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24622705 | 0.99 | HSD11B1 (0.32) | HTTPDE7APDE7BHSD11B1 | |
| SCHEMBL24622683 | 0.96 | HTT (0.35) | HTTHSD11B1MEN1ALDH1A1MAPT | |
| SCHEMBL24622660 | 0.95 | HTT (0.34) | HTTHSD11B1MEN1ALDH1A1MAPT | |
| SCHEMBL24622703 | 0.95 | HTT (0.34) | HTTHSD11B1MEN1ALDH1A1MAPT | |
| SCHEMBL24622891 | 0.92 | PDK2 (0.34) | HTTPDE7APDE7BHSD11B1MEN1 | |
| SCHEMBL23626217 | 0.91 | PDE7A (0.32) | PDE7APDE7BPDE4APDE4BPDE4C | |
| SCHEMBL24622659 | 0.91 | PDK2 (0.33) | HTTPDE7APDE7BHSD11B1 | |
| SCHEMBL24622729 | 0.90 | PDK2 (0.34) | HTTPDE7APDE7BHSD11B1 | |
| SCHEMBL24622682 | 0.89 | HSD11B1 (0.33) | HTTHSD11B1MEN1ALDH1A1MAPT | |
| SCHEMBL24608932 | 0.87 | PDK2 (0.35) | HTTHSD11B1MEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220049-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220049-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS | HCN2, EPCAM, EFNA1 | HTT 258/4885PDE7A 1184/4885PDE7B 2330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.